BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND BCL2, Bcl-2, 596, ENSG00000171791 AND Prognosis
119 results:

  • 1. Vitexicarpin Induces Apoptosis and Inhibits Metastatic Properties via the AKT-PRAS40 Pathway in Human Osteosarcoma.
    Yun HM; Kwon HS; Lee JY; Park KR
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612399
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP.
    Morales AE; Gumenick R; Genovese CM; Jang YY; Ouedraogo A; Ibáñez de Garayo M; Pannellini T; Patel S; Bott ME; Alvarez J; Mun SS; Totonchy J; Gautam A; Delgado de la Mora J; Chang S; Wirth D; Horenstein M; Dao T; Scheinberg DA; Rubinstein PG; Semeere A; Martin J; Godfrey CC; Moser CB; Matining RM; Campbell TB; Borok MZ; Krown SE; Cesarman E
    PLoS Pathog; 2024 Jan; 20(1):e1011881. PubMed ID: 38190392
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Multiproperty Polyethylenimine-Caged Platinum Nanoclusters Promote Apoptosis of Osteosarcoma Cells via Regulating the BAX-bcl-2/Caspase-3/PARP Axis.
    Wang J; Zhang M; Huang X; Yue H
    Mol Pharm; 2023 Nov; 20(11):5607-5615. PubMed ID: 37831437
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. BNIP3 as a potential biomarker for the identification of prognosis and diagnosis in solid tumours.
    Yu Q; Fu W; Fu Y; Ye W; Yan H; Yu Z; Li R; Cai Y; Chen Y; Wang L; Wei X; Chen Y; Zhang Y; Ying H; Tang F; Dai F; Han W
    Mol Cancer; 2023 Aug; 22(1):143. PubMed ID: 37649051
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Gambogenic acid induces cell death in human osteosarcoma through altering iron metabolism, disturbing the redox balance, and activating the P53 signaling pathway.
    Liu Z; Wang X; Li J; Yang X; Huang J; Ji C; Li X; Li L; Zhou J; Hu Y
    Chem Biol Interact; 2023 Sep; 382():110602. PubMed ID: 37302459
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Organoid models derived from patients with malignant phyllodes tumor of the breast.
    Chu X; Wu M; Yang J; Fu Y; Wang X; Wang H; Xiao Y; Chen D; He J
    Breast Cancer Res Treat; 2023 Jul; 200(2):193-201. PubMed ID: 37204665
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Silencing tumor-intrinsic HHLA2 potentiates the anti-tumoral effect of paclitaxel on MG63 cells: Another side of immune checkpoint.
    Ahangar NK; Khalaj-Kondori M; Alizadeh N; Mokhtarzadeh A; Baghbanzadeh A; Shadbad MA; Dolatkhah K; Baradaran B
    Gene; 2023 Mar; 855():147086. PubMed ID: 36535461
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. LRIG2 regulates cell proliferation, migration and apoptosis of osteosarcoma.
    Li ZQ; Liao WJ; Sun BL; Luo ZW; Zhong NS; Wu JB; Liu ZL; Liu JM
    BMC Cancer; 2022 Oct; 22(1):1029. PubMed ID: 36183058
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Diagnosis of Marginal Infiltration in Soft Tissue Sarcoma by Radiomics Approach Using T2-Weighted Dixon Sequence.
    Lee S; Jung JY; Nam Y; Jung CK; Lee SY; Lee J; Shin SH; Chung YG
    J Magn Reson Imaging; 2023 Mar; 57(3):752-760. PubMed ID: 35808915
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Knocking down Siglec-15 in osteosarcoma cells inhibits proliferation while promoting apoptosis and pyroptosis by targeting the Siglec-15/STAT3/bcl-2 pathway.
    Song K; Ma J; Gao Y; Qu Y; Ren C; Yan P; Zheng B; Yue B
    Adv Med Sci; 2022 Sep; 67(2):187-195. PubMed ID: 35398779
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Diagnostic and prognostic value of bcl-2 in uterine leiomyosarcoma.
    Travaglino A; Raffone A; Raimondo D; Gencarelli A; Esposito I; Gallo C; Improda FP; Vitale SG; Mollo A; Casadio P; Seracchioli R; Zullo F; Insabato L
    Arch Gynecol Obstet; 2023 Feb; 307(2):379-386. PubMed ID: 35344084
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinicopathological Features Associated with Microsatellite Instability/Mismatch Repair Deficiency in Uterine Carcinosarcoma: A Quantitative Systematic Review.
    Travaglino A; Raffone A; Santoro A; Raimondo D; Orsini B; Casadio P; Zullo F; Seracchioli R; Zannoni GF; Insabato L; Mollo A
    Pathobiology; 2022; 89(4):198-204. PubMed ID: 35231921
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical Characteristics, Pathology and Outcome of 237 Patients With Synovial Sarcoma: Single Center Experience.
    Cheng H; Yihebali C; Zhang H; Guo L; Shi S
    Int J Surg Pathol; 2022 Jun; 30(4):360-369. PubMed ID: 34866460
    [No Abstract]    [Full Text] [Related]  

  • 14. Surfactin induces ER stress-mediated apoptosis via IRE1-ASK1-JNK signaling in human osteosarcoma.
    Wang GS; Chen JY; Chen WC; Wei IC; Lin SW; Liao KW; Yang TS; Liu JF
    Environ Toxicol; 2022 Mar; 37(3):574-584. PubMed ID: 34850538
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. MicroRNA-221 Upregulates the Expression of P-gp and bcl-2 by Activating the Stat3 Pathway to Promote Doxorubicin Resistance in Osteosarcoma Cells.
    Liu Y; Liu X; Yang S
    Biol Pharm Bull; 2021 Jun; 44(6):861-868. PubMed ID: 33828027
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Sequential combinations of chemotherapeutic agents with BH3 mimetics to treat rhabdomyosarcoma and avoid resistance.
    Alcon C; Manzano-Muñoz A; Prada E; Mora J; Soriano A; Guillén G; Gallego S; Roma J; Samitier J; Villanueva A; Montero J
    Cell Death Dis; 2020 Aug; 11(8):634. PubMed ID: 32801295
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Surgical treatment of pediatric rhabdomyosarcoma in the parameningeal-nonparameningeal region.
    Liu Z; Zhu F; Cao W; Sun J; Zhang C; He Y
    J Craniomaxillofac Surg; 2020 Jan; 48(1):75-82. PubMed ID: 31902716
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinicopathological characteristics and survival outcomes in breast carcinosarcoma: A SEER population-based study.
    Lin S; Liu C; Tao Z; Zhang J; Hu X
    Breast; 2020 Feb; 49():157-164. PubMed ID: 31812891
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Toosendanin induces the apoptosis of human Ewing's sarcoma cells via the mitochondrial apoptotic pathway.
    Gao T; Xie A; Liu X; Zhan H; Zeng J; Dai M; Zhang B
    Mol Med Rep; 2019 Jul; 20(1):135-140. PubMed ID: 31115517
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Potent and PPARα-independent anti-proliferative action of the hypolipidemic drug fenofibrate in VEGF-dependent angiosarcomas in vitro.
    Majeed Y; Upadhyay R; Alhousseiny S; Taha T; Musthak A; Shaheen Y; Jameel M; Triggle CR; Ding H
    Sci Rep; 2019 Apr; 9(1):6316. PubMed ID: 31004117
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.